Raised interleukin 6 (IL-6) was found to be associated with chronic fatigue syndrome [27]. Thus indicating the possible association of raised inflammatory cytokines and persistence of post-COVID symptoms, which may have been countered by prophylaxis given to the patients. This evidence concerns the gene IL6 and myalgic encephalomeyelitis/chronic fatigue syndrome.